SCHEMBL5789117

SCHEMBL5789117

Cc1nc2c(c(=O)[nH]c(=O)n2COC(=O)C(C)(C)C)n1Cc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.51
KDM4E B2RXH2 7/20 0.51
MEN1 O00255 7/20 0.51
KMT2A Q03164 7/20 0.51
MAPT P10636 3/20 0.51
HPGD P15428 2/20 0.51
GAA P10253 1/20 0.51
HTT P42858 1/20 0.51
PKM P14618 3/20 0.49
MCL1 Q07820 2/20 0.49
ADORA3 P0DMS8 3/20 0.48
NPSR1 Q6W5P4 2/20 0.48
POLB P06746 4/20 0.47
TSHR P16473 1/20 0.46
HSD17B10 Q99714 1/20 0.46
RECQL P46063 1/20 0.46
BLM P54132 1/20 0.46
CACNA1B Q00975 1/20 0.46
APBA1 Q02410 1/20 0.46
TDP1 Q9NUW8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8140363 0.81 USP2 (0.45) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL2952786 0.81 BRD4 (0.59) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL9386107 0.79 ALDH1A1 (0.58) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL6348692 0.77 BRAF (0.72) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL5789121 0.76 KDM4E (0.55) ALDH1A1KDM4EMEN1KMT2APOLB
SCHEMBL9385820 0.72 KDM4E (0.38) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL6358370 0.69 PNP (0.42) KDM4E
Propane SCHEMBL28427086 0.68 ADORA3 (0.39) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL6095090 0.68 ALDH1A1 (0.70) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL6357936 0.68 LMNA (0.44) ALDH1A1KDM4EMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060100199-A1 Novel condensed imidazole derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2006-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060100199-A1 Novel condensed imidazole derivatives H1-2, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, H1-4 ALDH1A1 1467/4885KDM4E 3658/4885MEN1 164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.